Process for preparing purine compounds by reaction of a carbonitrile with formic acid
    16.
    发明授权
    Process for preparing purine compounds by reaction of a carbonitrile with formic acid 失效
    通过与形成酸反应的碳酸酯制备磷化合物的方法

    公开(公告)号:US3857842A

    公开(公告)日:1974-12-31

    申请号:US20576471

    申请日:1971-12-07

    申请人: SAGAMI CHEM RES

    发明人: ASAI N

    摘要: An improved process for preparing purine compounds of the formula

    WHEREIN X is selected from the group consisting of an amino and a hydroxy group, and Y is selected from the group consisting of an amino and a hydroxy group and hydrogen, which are useful as precursors for the synthesis of organic compounds, as well as a process for preparing a carboxyamide of the formula

    USEFUL AS AN INTERMEDIATE FOR THE SYNTHESIS OF THE ABOVE PURINE COMPOUNDS ARE

    摘要翻译: 制备式WHEREIN X的嘌呤化合物的改进方法是选自氨基和羟基,Y选自氨基和羟基和氢,其可用作 有机化合物的合成,以及制备下式的羧酰胺的方法有用的合成上述化合物的中间体被公开。 这些方法从具有下式的4(5) - 氨基咪唑-5(4) - 腈开始

    Substituted heterocyclic compounds
    19.
    发明授权
    Substituted heterocyclic compounds 有权
    取代的杂环化合物

    公开(公告)号:US08343961B2

    公开(公告)日:2013-01-01

    申请号:US12751238

    申请日:2010-03-31

    CPC分类号: C07D473/26 C07D487/04

    摘要: The present invention relates to substituted heterocyclic compounds and substituted tetrahydroisoquinoline compounds and methods of synthesizing these compounds. The present invention also relates to pharmaceutical compositions containing substituted benzodiazepine compounds and substituted tetrahydroisoquinoline compounds and methods of treating cell proliferative disorders, such as cancer, by administering these compounds or pharmaceutical compositions to subjects in need thereof.

    摘要翻译: 本发明涉及取代的杂环化合物和取代的四氢异喹啉化合物及其合成方法。 本发明还涉及含有取代的苯并二氮杂化合物和取代的四氢异喹啉化合物的药物组合物以及通过将这些化合物或药物组合物给予有需要的受试者来治疗细胞增殖性疾病如癌症的方法。

    Aminoheterocycle-substituted glycerols
    20.
    发明授权
    Aminoheterocycle-substituted glycerols 失效
    氨基杂环取代的甘油

    公开(公告)号:US5891881A

    公开(公告)日:1999-04-06

    申请号:US976408

    申请日:1997-11-21

    摘要: Aminoheterocycle-substituted glycerols of Formula I are disclosed: ##STR1## wherein one of A, B or C is --X--R, wherein X is --O-- or --S--, and R is a substituted or unsubstituted C.sub.12-24 alkyl or alkenyl, the substituent being one or more of halo, C.sub.1-3 alkoxy or cyano, provided that a double bond of the alkenyl does not originate at the carbon atom bound to X; and another of A, B or C is an aminoheterocycle ring substituent --Het--NH.sub.2, wherein Het is a 5 to 11-membered monocyclic, bicyclic or bicyclic fused heterocyclic ring moiety with at least 1 to 4 nitrogens atoms contained within the hetero cyclic moiety, one of which nitrogen atoms is bonded to the glycero carbon; and the remaining A, B, or C substituent is --OH. The compounds of Formula I, isomers, salts, pharmaceutical compositions and appliances incorporating the same, and methods of use thereof are also disclosed.

    摘要翻译: 公开了式I的氨基杂环取代的甘油:其中A,B或C中的一个为-XR,其中X为-O-或-S-,R为取代或未取代的C 12-24烷基或链烯基 所述取代基是卤素,C 1-3烷氧基或氰基中的一个或多个,条件是烯基的双键不是起始于与X结合的碳原子; A,B或C中的另一个是氨基杂环环取代基-Het-NH 2,其中Het是5至11元单环,双环或双环稠合杂环部分,其中杂环基部分内含有至少1至4个氮原子 其中氮原子之一与甘油碳键合; 其余的A,B或C取代基是-OH。 还公开了式I的化合物,异构体,盐,药物组合物和并入其的装置及其使用方法。